Sort
78,016 grants matching “breast cancer”
Obesity-driven endometrial hyperplasia in postmenopausal women: Synergistic role for insulin and estrone
$467,897Clare Ann Flannery · Yale University · R01 · FY2021 · HD
Fatty Acylation of Hedgehog and Wnt Proteins
$467,895Marilyn D Resh · Sloan-Kettering Inst Can Research · R01 · FY2019 · GM
Fatty Acylation of Hedgehog and Wnt Proteins
$467,895Marilyn D Resh · Sloan-Kettering Inst Can Research · R01 · FY2016 · GM
Molecularly-Targeted Ultrasound in Ovarian Cancer
$467,885Ahmed El Kaffas · Stanford University · R01 · FY2021 · CA
Molecular Targets for Cancer Detection and Treatment
$467,874William George Nelson · Johns Hopkins University · T32 · FY2008 · CA
Molecular Targets for Cancer Detection and Treatment
$467,852William George Nelson · Johns Hopkins University · T32 · FY2012 · CA
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy
$467,825James K Turkson · University Of Hawaii At Manoa · R01 · FY2014 · CA
Role Of Lipids In Colon, Breast, And Other Cancers
$467,820Thomas Eling · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Center of Excellence in Biobehavioral Approaches to Symptom Management
$467,789Rita H. Pickler · Virginia Commonwealth University · P30 · FY2010 · NR
Measuring and Modulating DNA Damage Surveillance Pathways
$467,789Eric T. Kool · Stanford University · R01 · FY2022 · CA
Determinants for genome-wide epigenomics in metastatic breast cancer
$467,778Terumi Kohwi-Shigematsu · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2012 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2017 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2016 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2020 · CA
A novel therapy for HER2 positive hormone refractory breast cancer
$467,753Anne W Hamburger · University Of Maryland Baltimore · RC1 · FY2009 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$467,748Elizabeth Mittendorf · Methodist Hospital Research Institute · U54 · FY2018 · CA
PI3K/PTEN/Akt signaling and the genesis of cancer
$467,725Nissim Hay · University Of Illinois At Chicago · R01 · FY2025 · CA
Moffitt Imaging Biomarker VAlidation Center
$467,624Matthew B. Schabath · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2021 · CA
TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients
$467,606Sanchita Bhatnagar · University Of California At Davis · R01 · FY2023 · CA
Role of T regulatory suppression in autoimmunity and cancer
$467,606Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Measuring extracellular pH in pre-clinical tumor models with CEST MRI
$467,603Mark David Pagel · University Of Arizona · R01 · FY2012 · CA
Mechanism of Intratumoral Transport of Particulate Drugs
$467,591Haifa Shen · Methodist Hospital Research Institute · R01 · FY2018 · CA
Diagnosis of Cancer in the Emergency Room - Explaining Persistent Disparities
$467,569Caroline Avery Thompson · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
PI3K/PTEN/Akt signaling and the genesis of cancer
$467,549Nissim Hay · University Of Illinois At Chicago · R01 · FY2023 · CA
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment
$467,521Benedict Shek Hang Law · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA